Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tremor | 3 | 2021 | 129 | 1.510 |
Why?
|
| Dystonia | 5 | 2023 | 171 | 1.340 |
Why?
|
| Dystonic Disorders | 3 | 2023 | 83 | 1.100 |
Why?
|
| Movement Disorders | 3 | 2022 | 221 | 0.940 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2023 | 14 | 0.890 |
Why?
|
| Brain Diseases | 2 | 2022 | 296 | 0.790 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2021 | 167 | 0.740 |
Why?
|
| Migraine with Aura | 1 | 2021 | 16 | 0.730 |
Why?
|
| Chorea | 1 | 2021 | 39 | 0.730 |
Why?
|
| Hemiplegia | 1 | 2021 | 40 | 0.730 |
Why?
|
| Jaw Diseases | 1 | 2020 | 3 | 0.720 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2021 | 98 | 0.700 |
Why?
|
| Tics | 1 | 2021 | 49 | 0.700 |
Why?
|
| Neuromuscular Agents | 1 | 2020 | 67 | 0.670 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 699 | 0.650 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3546 | 0.390 |
Why?
|
| Botulinum Toxins | 2 | 2023 | 119 | 0.350 |
Why?
|
| Phenotype | 3 | 2024 | 4229 | 0.230 |
Why?
|
| Receptors, AMPA | 1 | 2024 | 49 | 0.230 |
Why?
|
| Infant | 5 | 2024 | 12351 | 0.230 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2023 | 13 | 0.220 |
Why?
|
| Gain of Function Mutation | 1 | 2024 | 105 | 0.220 |
Why?
|
| Myoclonus | 1 | 2023 | 32 | 0.220 |
Why?
|
| Tic Disorders | 1 | 2024 | 78 | 0.220 |
Why?
|
| Loss of Function Mutation | 1 | 2024 | 142 | 0.210 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2022 | 17 | 0.200 |
Why?
|
| Self-Injurious Behavior | 1 | 2023 | 64 | 0.200 |
Why?
|
| Niacin | 1 | 2022 | 57 | 0.200 |
Why?
|
| Levodopa | 1 | 2021 | 90 | 0.190 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 75 | 0.190 |
Why?
|
| Child, Preschool | 6 | 2024 | 13888 | 0.190 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2021 | 19 | 0.180 |
Why?
|
| Iron | 1 | 2023 | 261 | 0.180 |
Why?
|
| Muscle Contraction | 1 | 2021 | 186 | 0.170 |
Why?
|
| Humans | 16 | 2024 | 123232 | 0.160 |
Why?
|
| Meningitis, Viral | 1 | 2018 | 10 | 0.160 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2024 | 485 | 0.160 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2018 | 12 | 0.160 |
Why?
|
| Myelitis | 1 | 2018 | 15 | 0.160 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 55 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2018 | 140 | 0.150 |
Why?
|
| Larynx | 1 | 2018 | 69 | 0.140 |
Why?
|
| West Nile virus | 1 | 2018 | 117 | 0.140 |
Why?
|
| Pedigree | 1 | 2020 | 1584 | 0.140 |
Why?
|
| West Nile Fever | 1 | 2018 | 139 | 0.140 |
Why?
|
| Chromosome Disorders | 1 | 2018 | 309 | 0.130 |
Why?
|
| Intellectual Disability | 1 | 2023 | 1042 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 249 | 0.130 |
Why?
|
| Male | 7 | 2024 | 60122 | 0.120 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 638 | 0.120 |
Why?
|
| Brain | 2 | 2023 | 2964 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 937 | 0.120 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 519 | 0.110 |
Why?
|
| Child | 7 | 2024 | 24241 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2021 | 12141 | 0.110 |
Why?
|
| Mutation | 2 | 2023 | 5775 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2010 | 299 | 0.070 |
Why?
|
| Female | 6 | 2024 | 65551 | 0.060 |
Why?
|
| Qb-SNARE Proteins | 1 | 2023 | 6 | 0.060 |
Why?
|
| Amines | 1 | 2022 | 36 | 0.050 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2022 | 15 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2023 | 56 | 0.050 |
Why?
|
| Injections | 1 | 2023 | 153 | 0.050 |
Why?
|
| Adolescent | 4 | 2024 | 19112 | 0.050 |
Why?
|
| Epilepsy | 1 | 2010 | 858 | 0.050 |
Why?
|
| Ataxia | 1 | 2023 | 168 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 225 | 0.050 |
Why?
|
| Pediatrics | 1 | 2010 | 1141 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2021 | 192 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 348 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2021 | 437 | 0.040 |
Why?
|
| Seizures | 1 | 2023 | 873 | 0.040 |
Why?
|
| Rats | 1 | 2022 | 3653 | 0.030 |
Why?
|
| Syndrome | 1 | 2018 | 1115 | 0.030 |
Why?
|
| Young Adult | 2 | 2024 | 8865 | 0.030 |
Why?
|
| California | 1 | 2010 | 128 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 16033 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 300 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 29072 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2010 | 375 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 1414 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 33765 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2010 | 3014 | 0.010 |
Why?
|